# Mihály Tapolyai

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mihaly-tapolyai/

## Facts

| Field | Value |
| --- | --- |
| Citations | 984 |
| Field | Dialysis and Renal Disease Management |
| h-index | 17 |
| i10-index | 26 |
| Last Known Institution | Semmelweis University |
| OpenAlex ID | https://openalex.org/A5070086186 |
| ORCID iD | 0000-0002-2915-3962 |
| Works | 69 |

## Researcher papers

- [Establishing a dialysis therapy/patient outcome link in intensive care unit acute dialysis for patients with acute renal failure](https://scholariq.org/papers/establishing-a-dialysis-therapy-patient-outcome-link-in-intensive-care-unit/)
- [What Dialysis Dose Should Be Provided in Acute Renal Failure? A Review](https://scholariq.org/papers/what-dialysis-dose-should-be-provided-in-acute-renal-failure-a-review/)
- [Bicarbonate dialysate for continuous renal replacement therapy in intensive care unit patients with acute renal failure](https://scholariq.org/papers/bicarbonate-dialysate-for-continuous-renal-replacement-therapy-in-intensive-care/)
- [High Prevalence of Liddle Syndrome Phenotype Among Hypertensive US Veterans in Northwest Louisiana](https://scholariq.org/papers/high-prevalence-of-liddle-syndrome-phenotype-among-hypertensive-us-veterans-in/)
- [Hemodialysis Is as Effective as Hemoperfusion for Drug Removal in Carbamazepine Poisoning](https://scholariq.org/papers/hemodialysis-is-as-effective-as-hemoperfusion-for-drug-removal-in-carbamazepine/)
- [Volume estimation in dialysis patients: The concordance of brain‐type natriuretic peptide measurements and bioimpedance values](https://scholariq.org/papers/volume-estimation-in-dialysis-patients-the-concordance-of-brain-type-natriuretic/)
- [Dialysis Patients' Fluid Overload, Antihypertensive Medications, and Obesity](https://scholariq.org/papers/dialysis-patients-fluid-overload-antihypertensive-medications-and-obesity/)
- [Which fluid space is affected by ultrafiltration during hemodiafiltration?](https://scholariq.org/papers/which-fluid-space-is-affected-by-ultrafiltration-during-hemodiafiltration/)
- [Management of chronic kidney disease: The current novel and forgotten therapies](https://scholariq.org/papers/management-of-chronic-kidney-disease-the-current-novel-and-forgotten-therapies/)
- [r.hu-Erythropoietin (EPO) treatment of pre-ESRD patients slows the rate of progression of renal decline](https://scholariq.org/papers/r-hu-erythropoietin-epo-treatment-of-pre-esrd-patients-slows-the-rate-of/)
- [Safety of total dose iron dextran infusion in geriatric patients with chronic kidney disease and iron deficiency anemia](https://scholariq.org/papers/safety-of-total-dose-iron-dextran-infusion-in-geriatric-patients-with-chronic/)

## Researcher topics

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Acute Kidney Injury Research](https://scholariq.org/topics/acute-kidney-injury-research/)
- [Central Venous Catheters and Hemodialysis](https://scholariq.org/topics/central-venous-catheters-and-hemodialysis/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)

## Researcher university

- [Semmelweis University](https://scholariq.org/institutions/semmelweis-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.